Diagnostic usefulness of histamine release test (HRT) and skin tests in IgE-mediated allergy to clavulanic acid
© Pineda et al; licensee BioMed Central Ltd. 2014
Published: 18 July 2014
Clavulanic acid (CLV) is an â-lactam antibiotic highly consumed in combination with amoxicillin (AX). In the last years, CLV-related hypersensitivity reactions have been reported, the diagnosis being mainly confirmed by skin and drug provocation tests (DPT)
Evaluation of a group of patients with immediate hypersensitivity reactions to CLV using skin tests and in vitro tests such as direct and passive sensitization HRT
Nineteen patients with an immediate hypersensitivity reaction after AX-CLV administration were evaluated. Skin tests were done with PPL, DM, AX and CLV (DIATER, Madrid, Spain). Controls (n=21) with proven AX-CLV tolerance were included in the context of a Spanish cross-sectional multicentric study including five hospitals. In vitro tests were performed by direct and passive sensitization HRT (Reflab, Copenhagen, Denmark) using AX and CLV at different concentrations. Tolerance to AX was assessed by DPT.
Patients' clinical manifestations consisted of anaphylaxis (n=7), urticaria (n=9) or angioedema/urticaria (n=3). All patients had skin test negative to PPL, DM, and AX and positive to CLV (2 by prick test at 20 mg/mL, and 17 by intradermal testing at 0.5 mg/mL (n=2), 5 mg/mL (n=9) and 20 mg/mL (n=6). AX DPT test was negative, thus confirming a CLV selective reaction. Skin testing was negative in all controls. Direct HRT sensitivity and specificity were 77.8% and 66.7%, respectively, and for passive sensitization HTR, sensitivity and specificity were 78.9% and 76.2%, respectively. AX HRT was negative in all patients
High sensitivity and specificity rates shown by passive sensitization HRT support that CLV-related hypersensitivity reactions are IgE-mediated. Also of interest, skin tests are becoming a useful method for the diagnosis of this condition.
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.